Dual Inhibition of CYP3A4 by Voriconazole and Clarithromycin Influences Tacrolimus Pharmacokinetics: Case Series Study

Eur J Drug Metab Pharmacokinet. 2022 Nov;47(6):889-893. doi: 10.1007/s13318-022-00790-9. Epub 2022 Aug 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clarithromycin / pharmacology
  • Cytochrome P-450 CYP3A* / genetics
  • Genotype
  • Immunosuppressive Agents / pharmacology
  • Tacrolimus* / pharmacology
  • Voriconazole / pharmacology

Substances

  • Tacrolimus
  • Cytochrome P-450 CYP3A
  • Voriconazole
  • Clarithromycin
  • Immunosuppressive Agents